METHODS FOR CONVERSION OF CARBOHYDRATES IN IONIC LIQUIDS TO VALUE-ADDED CHEMICALS
申请人:Zhao Haibo
公开号:US20080033187A1
公开(公告)日:2008-02-07
Methods are described for converting carbohydrates including, e.g., monosaccharides, disaccharides, and polysaccharides in ionic liquids to value-added chemicals including furans, useful as chemical intermediates and/or feedstocks. Fructose is converted to 5-hydroxylmethylfurfural (HMF) in the presence of metal halide and acid catalysts. Glucose is effectively converted to HMF in the presence of chromium chloride catalysts. Yields of up to about 70% are achieved with low levels of impurities such as levulinic acid.
[EN] IN VIVO IMMOBILIZATION OF PROTEINS<br/>[FR] IMMOBILISATION IN VIVO DE PROTÉINES
申请人:UNIV HONG KONG CHINESE
公开号:WO2020216322A1
公开(公告)日:2020-10-29
Provide is a novel system for immobilizing recombinantly produced proteins by entrapping them in crystals of co-expressed proteins that are capable of self-crystallization. Related compositions and as well as methods of making and using the immobilized proteins are also described.
Chiral diphosphorus compounds and their transition metal complexes
申请人:Meseguer Benjamin
公开号:US20070155971A1
公开(公告)日:2007-07-05
The present invention relates to chiral diphosphorus compounds and their transition metal complexes, to a process for preparing chiral diphosphorus compounds and their transition metal complexes and also to their use in asymmetric syntheses.
Procédé de sulfatation de glycosaminoglycanes, nouveaux glycosaminoglycanes obtenus et leurs applications biologiques
申请人:SANOFI
公开号:EP0214879A2
公开(公告)日:1987-03-18
Selon le procédé de l'invention on soumet un glycosaminoglycane mis en oeuvre sous forme d'un sel soluble en milieu organique à l'action d' un agent de sulfatation donné.
根据本发明的工艺,以可溶于有机介质的盐形式使用的糖胺聚糖会受到特定硫化剂的作用。
Monoclonal antibody, a process for its preparation and the use thereof
申请人:CARMEDA AB
公开号:EP0313538A2
公开(公告)日:1989-04-26
A monoclonal antibody which has specificity towards an antigenic determinant of a saccharide having in reducing-terminal position a 2,5-anhydro hexose residue;
a process for the preparation of such monoclonal antibody;
a process for isolating saccharides; and
a process for determining the presence of a saccharide.